Toggle Menu
Filings Insight
최근공시
Avalo Therapeutics, Inc.
0001534120 Nasdaq
3 - Avalo Therapeutics, Inc. (0001534120) (Issuer)[0]
[3]
Initial statement of beneficial ownership of securities
(접수일: 2025-10-02[적용일2025-10-01])
[REPORTING-OWNER]
Lind Kevin Robert |
[ISSUER]
Avalo Therapeutics, Inc. |
/ 0
3 - Avalo Therapeutics, Inc. (0001534120) (Issuer) | Filings Insight
